Routine Antibiotics Appear to Hold No Benefit in Non-Severe COVID-19

Routine Antibiotics Appear to Hold No Benefit in Non-Severe COVID-19

(MedPage Today) -- The use of antibiotics in patients hospitalized with non-severe COVID-19 was not associated with better outcomes, a large retrospective cohort study found. Among more than half a million U.S. patients with COVID, those given...

The Argument Against Routine Antibiotics for Patients With Nonsevere COVID-19

Over 500,000 US patients hospitalized with nonsevere COVID-19 saw no clinically significant benefit and potential harm associated with routine early antibiotic treatment, supporting antibiotic stewardship to limit unnecessary use.

Antibiotic Use in Hospitalized Patients with Mild COVID-19: Evaluating

In a significant and comprehensive cohort study focusing on hospitalized patients with nonsevere COVID-19, researchers have scrutinized the impact of early antibiotic therapy on clinical outcomes. The investigation, encompassing a large patient population, reveals that the administration of antibiotics at the early stages of hospitalization does not confer any clinically meaningful benefits in terms of morbidity or recovery trajectories. These f…

The South Centre | SC Webinar Report – AMS, COVID-19 & Pandemic Preparedness, May 2025

Webinar Report: Advancing Antimicrobial Stewardship Policies: Lessons from the COVID-19 Pandemic and Priorities for Future Health Emergencies By Dr Rasha Abdelsalam Elshenawy Our recent South Centre webinar examined how the pandemic created a dual challenge for global health: – MISUSE: 35-75% of hospitalized COVID-19 patients received antibiotics despite low bacterial co-infection rates. – ACCESS BARRIERS: The pandemic disrupted supply chains an…